Natco Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LANTHANUM CARBONATE DIHYDRATE, with a corresponding US DMF Number 22050.
Remarkably, this DMF maintains an Active status since its submission on October 02, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 14, 2015, and payment made on September 30, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II